Albert Luderer joins BioNano Genomics board
This article was originally published in Scrip
Executive Summary
BioNano Genomics, a company using its nanoAnalyzer technology platform to gain a better understanding of genomes, has elected Dr Albert Luderer to its board of directors. Dr Luderer has over 30 years' experience in biotech, having previously served as president and CEO of BioTrove. He is currently CEO and director of Integrated Diagnostics.